Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.

Crabol Y, Terrier B, Rozenberg F, Pestre V, Legendre C, Hermine O, Montagnier-Petrissans C, Guillevin L, Mouthon L; Groupe d'experts de l'Assistance Publique-Hôpitaux de Paris.

Clin Infect Dis. 2013 Apr;56(7):968-77. doi: 10.1093/cid/cis1046. Epub 2012 Dec 12. Review.

PMID:
23243178
2.
3.

Human parvovirus B19 infection induced pure red cell aplasia in liver transplant recipients.

Zhang M, Zhong X, Zhang W, Xu J, Zhang M, Shen Y, Wang W, Zheng S.

Int J Clin Pract Suppl. 2015 May;(183):29-34. doi: 10.1111/ijcp.12664.

PMID:
26177162
4.

Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.

Wong TY, Chan PK, Leung CB, Szeto CC, Tam JS, Li PK.

Am J Kidney Dis. 1999 Dec;34(6):1132-6. Review.

PMID:
10585325
5.

Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.

Subtirelu MM, Flynn JT, Schechner RS, Pullman JM, Feuerstein D, Del Rio M.

Pediatr Transplant. 2005 Dec;9(6):801-4.

PMID:
16269055
6.

Red cell aplasia caused by parvovirus B19 in AIDS: use of i.v. immunoglobulin.

Koduri PR, Kumapley R, Khokha ND, Patel AR.

Ann Hematol. 1997 Jul-Aug;75(1-2):67-8.

PMID:
9322687
7.

Parvovirus B19-related anemia in HIV-infected patients.

Koduri PR.

AIDS Patient Care STDS. 2000 Jan;14(1):7-11.

PMID:
12240888
8.

Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease.

Katragadda L, Shahid Z, Restrepo A, Muzaffar J, Alapat D, Anaissie E.

Transpl Infect Dis. 2013 Aug;15(4):354-60. doi: 10.1111/tid.12067. Epub 2013 Apr 11.

PMID:
23578205
9.

Costs of intravenous immunoglobulin therapy in patients with unconfirmed parvovirus b19 pure red cell aplasia.

Mouthon L, Michel M, Gandré C, Montagnier-Petrissans C, Chevreul K.

Clin Infect Dis. 2015 Feb 1;60(3):488. doi: 10.1093/cid/ciu828. Epub 2014 Oct 21. No abstract available.

PMID:
25336624
10.

Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature.

Liang TB, Li DL, Yu J, Bai XL, Liang L, Xu SG, Wang WL, Shen Y, Zhang M, Zheng SS.

World J Gastroenterol. 2007 Apr 7;13(13):2007-10. Review.

11.

Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia.

Mouthon L, Guillevin L, Tellier Z.

Autoimmun Rev. 2005 Jun;4(5):264-9. Epub 2004 Nov 13. Review.

PMID:
15990072
12.

A case of recurrent autoimmune hemolytic anemia during remission associated with acute pure red cell aplasia and hemophagocytic syndrome due to human parvovirus B19 infection successfully treated by steroid pulse therapy with a review of the literature.

Sekiguchi Y, Shimada A, Imai H, Wakabayashi M, Sugimoto K, Nakamura N, Sawada T, Komatsu N, Noguchi M.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2624-35. eCollection 2014. Review.

13.

A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection.

Choi SH, Chang SP, Won JC, Lee JS, Chi HS, Yang WS, Park SK.

Scand J Infect Dis. 2002;34(1):71-5. Review.

PMID:
11874173
14.

Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.

Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres AS, Raab U, Neumayer HH, Meisel H, Modrow S.

J Med Virol. 2005 Jan;75(1):161-9.

PMID:
15543575
15.

Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation.

Ahsan N, Holman MJ, Gocke CD, Groff JA, Yang HC.

Clin Transplant. 1997 Aug;11(4):265-70. Review.

PMID:
9267713
16.

Chronic persistent parvovirus B19 bone marrow infection resulting in transfusion-dependent pure red cell aplasia in multiple myeloma after allogeneic haematopoietic stem cell transplantation and severe graft versus host disease.

Karrasch M, Schmidt V, Hammer A, Hochhaus A, Rosée P, Petersen I, Sauerbrei A, Baier M, Sayer HG, Hermann B.

Hematology. 2017 Mar;22(2):93-98. doi: 10.1080/10245332.2016.1183288. Epub 2016 Jun 16.

PMID:
27311084
17.

Parvovirus B 19 (PVB19) induced pure red cell aplasia (PRCA) in immunocompromised patient after liver transplantation.

Mrzljak A, Kardum-Skelin I, Cvrlje VC, Kanizaj TF, Sustercić D, Gustin D, Kocman B.

Coll Antropol. 2010 Mar;34(1):271-4.

PMID:
20432761
18.

Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.

Tavil B, Sanal O, Turul T, Yel L, Gurgey A, Gumruk F.

Pediatr Hematol Oncol. 2009 Mar;26(2):63-8. doi: 10.1080/08880010902754735.

PMID:
19322736
19.

Parvovirus B19-induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment.

Arzouk N, Snanoudj R, Beauchamp-Nicoud A, Mourad G, Charpentier B, Tchernia G, Durrbach A.

Transpl Int. 2006 Feb;19(2):166-9.

20.

Severe anemia from parvovirus b19 infection in pediatric renal transplant recipients: two case reports.

Pinto V, Grandy J, Zambrano P, Corta B, Salas P, Salgado I, Santander J, Salgado C, Chadid J, Iñiguez R.

Transplant Proc. 2008 Nov;40(9):3261-4. doi: 10.1016/j.transproceed.2008.03.127. Epub 2008 Jun 30.

PMID:
19010248

Supplemental Content

Support Center